Head of Department, Ms Päivi Ylä-Kotola M.Sc. (Consumer Economics), B.Sc. (Pharm.)

More than five years of experience in Pharmacovigilance as a Pharmacovigilance Manager/Head of Pharmacovigilance at sanofi-aventis Oy. Over seven years of experience in Drug Regulatory Affairs as Coordinator for Marketing Authorizations at the Finnish Medicines Agency (FIMEA) including a 2-year secondment as National Expert Detaché  at the European Medicines Agency (EMA) in London.

Pharmacovigilance Specialist, Ms Tanja Moilanen (registered nurse)

Tanja joined Farenta in the beginning of 2010. Before that nearly two years of experience in pharmacovigilance including Patient Safety Manager duties at AstraZeneca Oy and Three years of experience within clinical trials as Clinical Research Associate and as Clinical Trial Assistant.”

Pharmacovigilance Specialist, Ms Emily Laajanen, B.Sc. (Pharm.)

Emily joined Farenta in October 2010. Before that she worked for three years as Drug Safety Officer at Pfizer Finland.

Services:

• pre- and post-marketing authorisation adverse event handling
• literature follow-up
• Periodic Safety Update Reports (PSUR)
• pharmacovigilance training and coaching
• consultation (pharmacovigilance audits and inspections)
• product complaint handling

For more information, please contact our Sales Director:

Mika Pulkkinen
mika.pulkkinen[a]farenta.fi
+358 (0)10 4398 233